Catalyst Wire Dossier Catalyst Wire Dossier

Detoxified J5 Core Glycolipid/Group B Meningococcal Outer Membrane Protein Vaccine

Detoxified J5 core glycolipid/Group B meningococcal outer membrane protein vaccine · National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Detoxified J5 Core Glycolipid/Group B Meningococcal Outer Membrane Protein Vaccine, covering 2014-01-31 to 2014-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant [Phase 1]

See pricing